Close mobile menu×
Close mobile menu

Gabrielle Page-Wilson, MD

Board Certifications: 
Internal Medicine, Endocrinology, Diabetes and Metabolism
Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Clinical Expertise

  • Neuroendocrine Carcinoma
  • Neuroendocrine Tumor
  • Neuroendocrinology

Education & Training

  • Harvard Medical School
  • Residency: Brigham and Women's Hospital
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • FASEB MARC Travel Award (2004)
  • Wilbert C. Jordan Research Forum Award (2004)
  • Eastern Atlantic Research Forum Award (2004)
  • The Endocrine Society Outstanding Abstract Award (2010)

About Gabrielle Page-Wilson

Dr. Gabrielle Page-Wilson is an Assistant Professor of Clinical Medicine in the Division of Endocrinology at Columbia University. She graduated from Harvard College with a degree in Psychology in 1999, and then earned her M.D. from Harvard Medical School in 2005 where she graduated with honors in the field of Reproductive Endocrinology. Dr. Page-Wilson completed her internship and residency training in Internal Medicine at Brigham and Women's Hospital in Boston (2008) and her Endocrinology, Diabetes and Metabolism fellowship training at Columbia University Medical Center (2011).

She is board certified in both Internal Medicine and Endocrinology, Diabetes and Metabolism.

Academic Titles

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Room 9-904
New York, New York 10032
Primary

Research

Dr. Page-Wilson has several research interests including 1) the impact of estrogen replacement in post-menopausal women on body composition and adiposity, 2) appetite regulation in pregnancy, and 3) novel approaches to the diagnosis and treatment of pituitary tumors with a special focus on Cushing's disease and prolactinomas. She has received an Endocrine Fellows Foundation Research Grant in Diabetes, Obesity and Fat Cell Biology (2009), and an Irving Institute/Clinical Trials Office Pilot Award (2011). Dr. Page-Wilson sees patients in the Neuroendocrine Unit and attends on the inpatient Neuroendocrine consult service and the inpatient Endocrinology consult service, as well as in the outpatient General Endocrine clinic at the Columbia University Medical Center. Her special clinical interests include Cushing's Syndrome, Hyperprolactinemia, Menopause, and PCOS. 

Grants

ANOPEN-LABEL EXTENSION STUDY OF LEVOKETOCONAZOLE (2S,4R-KETOCONAZOLE) IN THE TREATMENT OF ENDOGENOUS CUSHING?S SYNDROME (P&S Industry Clinical Trial)

May 14 2020 - May 14 2025

NEW YORK OBESITY RESEARCH CENTER (Federal Gov)

Dec 1 1996 - Mar 31 2021

NEW YORK OBESITY RESEARCH CENTER (Federal Gov)

Apr 15 2016 - Mar 31 2021

A NEW THERAPEUTIC OPTION FOR THE TREATMENT OF PROLACTINOMAS (Federal Gov)

Sep 16 2016 - Jun 30 2020

A NEW THERAPEUTIC OPTION FOR THE TREATMENT OF PROLACTINOMAS (Federal Gov)

Sep 16 2016 - Jun 30 2019

NOVEL APPROACHES TO THE DIFFERENTIAL DIAGNOSIS AND EVALUATION OF ACTH-DEPENDENT CUSHING S SYNDROME (Private)

Jan 1 2014 - Dec 31 2017

CSFNEUROPEPTIDE, HORMONAL, AND METABOLOMIC ANALYSIS IN HUMAN ENERGY BALANCE (Federal Gov)

Sep 20 2011 - Jul 31 2016

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Sep 30 2006 - Jun 30 2016

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Sep 30 2006 - Jun 30 2016

EFFECTS OF EARLY ESTRADIOL REPLACMENT ON ADIPOSE TISSUE INFL AMMATION AND METABOLISM IN POSTMENOPAUSAL WOMEN (Private)

Jul 1 2010 - Jun 30 2012